ARCT — Arcturus Therapeutics Holdings Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1768224 ·
Last close
$6.97
Market Cap
$198.11M
52W High
$9.58
52W Low
$6.67
ADV30
481,875
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 610,000 | — | -28,931,000 | -26,964,000 | 245,411,000 | 211,375,000 | 54,049,000 |
| Dec 2025 | 3,081,000 | — | -31,307,000 | -29,079,000 | 271,148,000 | 230,909,000 | 57,163,000 |
| Sep 2025 | 14,153,000 | — | -16,512,000 | -13,448,000 | 282,343,000 | 180,360,000 | 57,784,000 |
| Jun 2025 | 24,510,000 | — | -11,616,000 | -9,180,000 | 309,270,000 | 196,467,000 | 78,217,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-74,271,000
Investing CF
$-230,000
Financing CF
$13,382,000
CapEx
$-398,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-2.38
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-514,590,000
Inventory
—
Receivables
$5,564,000
ST Investments
—
EBIT TTM
$-65,775,000
Pretax Income TTM
$-65,783,000
Interest Exp TTM
$0
Analysts
10
Yahoo Snapshot (yfinance, live)
Total Revenue
$54,710,000
EBITDA
$-85,483,000
Free Cash Flow
$11,289,250
Enterprise Value
$16,121,174
Total Cash
$211,375,008
Total Debt
$23,987,000
Shares Out
28,423,069
Trailing EPS
$-2.83
Book Value
$6.73
ROE
-37.0%
ROA
-19.1%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 67,221,000 | -76,260,000 | -65,783,000 | 271,148,000 | 57,163,000 | — | -74,271,000 |
| Dec 2024 | 138,389,000 | -95,669,000 | -80,941,000 | 344,069,000 | 103,091,000 | — | -59,747,000 |
| Dec 2023 | 157,748,000 | -78,205,000 | -29,725,000 | 429,402,000 | 150,889,000 | — | -18,099,000 |
| Dec 2022 | 205,755,000 | 12,177,000 | 9,349,000 | 450,387,000 | 180,075,000 | — | 31,993,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-4.02
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| TNXP | Tonix Pharmaceuticals Holding Corp. | $199.74M | $12.53 | — |
| WHWK | Whitehawk Therapeutics, Inc. | $196.33M | $3.97 | — |
| NGEN | NERVGEN PHARMA CORP. | $200.06M | $1.88 | — |
| IMUX | IMMUNIC, INC. | $201.19M | $14.77 | — |
| MSLE | Satellos Bioscience Inc. | $203.94M | $9.79 | — |
News headlines (Yahoo Finance, 1h cache)
Arcturus Therapeutics (ARCT) Stock Jumps 5.7%: Will It Continue to Soar?
2026-07-03 11:06 · Yahoo
Arcturus Therapeutics Announces Strategic Collaboration with Thermo Fisher Scientific to Advance ARCT-032 for Cystic Fibrosis
2026-07-02 11:00 · Yahoo
Arcturus Therapeutics Highlights mRNA Pipeline, CF Data and Vaccine Expansion at Jefferies
2026-06-05 09:02 · Yahoo
Arcturus Therapeutics Holdings Inc. Q1 2026 Earnings Call Summary
2026-05-08 12:30 · Yahoo
Arcturus Therapeutics (ARCT) Reports Q1 Loss, Lags Revenue Estimates
2026-05-07 21:55 · Yahoo
Arcturus Therapeutics Q1 Earnings Call Highlights
2026-05-07 21:39 · Yahoo
Illumina (ILMN) Tops Q1 Earnings and Revenue Estimates
2026-04-30 22:25 · Yahoo
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
2026-03-25 15:12 · Yahoo
Arcturus Therapeutics Refocuses on Rare Disease mRNA Pipeline After COVID Vaccine Success at ROTH Conf
2026-03-23 18:47 · Yahoo
These Are the Only 3 Stocks That Cathie Wood Bought Last Week
2026-03-23 11:27 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.